Search Clinical Trials
Our researchers are currently in need of adult and pediatric study participants to help us pursue better treatments and cures. Participants may receive medical evaluations and procedures, study medication, disease-related education and possible financial compensation for time, travel and participation.
Select a Condition or Specialty
- Allergy
- Alpha-1 Antitrypsin Deficiency
- Asthma
- Cardiology
- Chronic Obstructive Pulmonary Disease (COPD)
- COVID-19 (Coronavirus)
- Cystic Fibrosis
- Eczema (Atopic Dermatitis)
- Environmental & Occupational Health
- Eosinophilic Granulomatosis with Polyangiitis (EGPA)
- Food Allergy
- Gastroenterology
- Idiopathic Pulmonary Fibrosis (IPF)
- Interstitial Lung Disease (Pulmonary Fibrosis)
- Lung Cancer
- Oncology
- Pulmonary Hypertension (PH)
- Respiratory (Pulmonary)
- Rheumatology
- Sarcoidosis
- Sleep
All Clinical Trials

Possible Treatment for Post-COVID POTS
Postural Orthostatic Tachycardia Syndrome, or POTS, is a chronic condition that involves sudden, rapid increases in heart rate when sitting or standing. This condition can disrupt daily life and trigger other symptoms such as fatigue, dizziness or vertigo. Research has linked POTS symptoms to long-haul COVID-19 infections, but the connection between these conditions is still being studied.
- Gender
- Any
- Ages
- 18+
- Compensation
- Provided
- Time Required
- 17 visits over approximately 60 weeks (15 months). The visits will be divided up into four phases: a screening period (4 weeks), a double-blind treatment period (24 weeks), an open-label treatment period (28 weeks) and a follow-up period (4 weeks).

New Trial Medication for Pulmonary Arterial Hypertension
By adding a new investigational Pulmonary Arterial Hypertension (PAH) medication to your current therapy, you could experience relaxed and widened artery walls.
- Gender
- Any
- Ages
- 18-75
- Compensation
- Provided
- Time Required
- Up to 42 months
Adult Trials

Possible Treatment for Post-COVID POTS
Postural Orthostatic Tachycardia Syndrome, or POTS, is a chronic condition that involves sudden, rapid increases in heart rate when sitting or standing. This condition can disrupt daily life and trigger other symptoms such as fatigue, dizziness or vertigo. Research has linked POTS symptoms to long-haul COVID-19 infections, but the connection between these conditions is still being studied.
- Gender
- Any
- Ages
- 18+
- Compensation
- Provided
- Time Required
- 17 visits over approximately 60 weeks (15 months). The visits will be divided up into four phases: a screening period (4 weeks), a double-blind treatment period (24 weeks), an open-label treatment period (28 weeks) and a follow-up period (4 weeks).

New Trial Medication for Pulmonary Arterial Hypertension
By adding a new investigational Pulmonary Arterial Hypertension (PAH) medication to your current therapy, you could experience relaxed and widened artery walls.
- Gender
- Any
- Ages
- 18-75
- Compensation
- Provided
- Time Required
- Up to 42 months
Pediatric Trials
Healthy Participant Trials

Possible Treatment for Post-COVID POTS
Postural Orthostatic Tachycardia Syndrome, or POTS, is a chronic condition that involves sudden, rapid increases in heart rate when sitting or standing. This condition can disrupt daily life and trigger other symptoms such as fatigue, dizziness or vertigo. Research has linked POTS symptoms to long-haul COVID-19 infections, but the connection between these conditions is still being studied.
- Gender
- Any
- Ages
- 18+
- Compensation
- Provided
- Time Required
- 17 visits over approximately 60 weeks (15 months). The visits will be divided up into four phases: a screening period (4 weeks), a double-blind treatment period (24 weeks), an open-label treatment period (28 weeks) and a follow-up period (4 weeks).